EFFECTS OF DARIDOREXANT ON SLEEP AND DAYTIME FUNCTIONING IN OLDER PATIENTS WITH INSOMNIA DISORDER

被引:0
|
作者
Fietze, I. [1 ]
Bassetti, C. [2 ]
Mayleben, D. [3 ]
Gimona, A. [4 ]
Pain, S. [4 ]
Kinter, D. Seboek [4 ]
机构
[1] Univ Hosp, Ctr Sleep Med, Charite, Berlin, Germany
[2] Univ Bern, Inselspital, Bern, Switzerland
[3] CTI Clin Res Ctr, Cincinnati, OH USA
[4] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S117 / S118
页数:2
相关论文
共 50 条
  • [1] EFFECTS OF DARIDOREXANT ON SLEEP AND DAYTIME FUNCTIONING IN OLDER ADULTS WITH INSOMNIA
    Fietze, Ingo
    Bassetti, Claudio
    Mayleben, David
    Gimona, Alberto
    Pain, Scott
    McCall, William
    Kinter, Dalma Seboek
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S69 - S70
  • [2] Daridorexant is Efficacious in Improving Sleep as Well as Daytime Functioning in Insomnia Patients
    Kinter, Dalma Seboek
    Mayleben, David
    Fietze, Ingo
    Zammit, Gary
    Bassetti, Claudio
    Leger, Damien
    Post, Anke
    Pain, Scott
    Roth, Thomas
    Mignot, Emmanuel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 136 - 137
  • [3] DARIDOREXANT IS SAFE AND IMPROVES BOTH SLEEP AND DAYTIME FUNCTIONING IN ELDERLY PATIENTS WITH INSOMNIA
    Fietze, Ingo
    Bassetti, Claudio
    Mayleben, David
    Gimona, Alberto
    Pain, Scott
    Kinter, Dalma Seboek
    [J]. SLEEP, 2021, 44 : A138 - A139
  • [4] EFFICACY OF LONG-TERM TREATMENT WITH DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER ON SLEEP AND DAYTIME FUNCTIONING: A POST-HOC ANALYSIS
    Dauvilliers, Y.
    Benes, H.
    Garcia-Borreguero, D.
    Kunz, D.
    Plazzi, G.
    Thein, S.
    Coloma, P.
    Rausch, M.
    Sassi-Sayadi, M.
    Kinter, D. Seboek
    [J]. SLEEP MEDICINE, 2022, 100 : S119 - S119
  • [5] Understanding daytime functioning in insomnia: responder and correlation analyses in patients treated with daridorexant
    Pierre-Philippe Luyet
    Antonio Olivieri
    Guy Braunstein
    [J]. Sleep Science and Practice, 7 (1)
  • [6] EFFECTS OF DARIDOREXANT ON TOTAL SLEEP TIME (TST) AND SLEEP STAGE PROPORTIONS IN PATIENTS WITH INSOMNIA DISORDER
    Zammit, G.
    Mayleben, D.
    Fietze, I.
    Pain, S.
    Gimona, A.
    Kinter, D. Seboek
    Dauvilliers, Y.
    [J]. SLEEP MEDICINE, 2022, 100 : S118 - S118
  • [7] NOCTURNAL SUBJECTIVE SLEEP AND DAYTIME COGNITIVE FUNCTIONING IN OLDER ADULTS WITH INSOMNIA
    Dzierzewski, J. M.
    McCrae, C. S.
    Marsiske, M.
    McCoy, K.
    McNamara, J.
    Dautovich, N.
    Stripling, A. M.
    Ross, A.
    [J]. GERONTOLOGIST, 2009, 49 : 190 - 190
  • [8] Daridorexant, a novel dual orexin receptor antagonist, delivers significant improvement in sleep parameters and daytime function for patients with insomnia disorder
    Roth, T.
    Zammit, G.
    Mignot, E.
    Leger, D.
    Bassetti, C.
    Pain, S.
    Kinter, D. Seboek
    [J]. JOURNAL OF SLEEP RESEARCH, 2020, 29 : 152 - 152
  • [9] Primary versus secondary insomnia in older adults: Subjective sleep and daytime functioning
    Lichstein, KL
    Durrence, HH
    Riedel, BW
    Bayen, UJ
    [J]. PSYCHOLOGY AND AGING, 2001, 16 (02) : 264 - 271
  • [10] Daridorexant for insomnia disorder
    Spiegelhalder, Kai
    Feige, Bernd
    Riemann, Dieter
    Kyle, Simon D.
    [J]. LANCET NEUROLOGY, 2022, 21 (02): : 104 - 105